A型肉毒神经毒素功能域抗原的免疫学特性及免疫保护效力
本研究制备并鉴定了A型肉毒神经毒素的一系列重组功能域抗原,比较其免疫保护效力。结果显示所有抗原均产生强体液免疫应答,但仅Hc和HN-L抗原提供完全免疫保护;Hc域抗原的保护效力优于HN-L,与全长毒素相当。
要点
- 所有重组功能域抗原均诱导强体液免疫应答,但保护效果不同。
- 仅Hc和HN-L抗原提供完全免疫保护。
- Hc域抗原保护效力优于HN-L,与全长毒素免疫效果相当。
核心结论
- Hc域抗原诱导强保护性免疫应答,为基于Hc的A型肉毒神经毒素亚单位疫苗开发提供基础数据和理论支持。
- 受体结合域Hc有望作为A型肉毒神经毒素重组亚单位疫苗的靶抗原,替代类毒素疫苗。
研究设计与样本
- 本研究制备并鉴定了一系列A型肉毒神经毒素重组功能域抗原,并探索和比较其免疫保护效力。
主要发现
- 所有抗原均产生强体液免疫应答,但其对毒素的保护效果不同。
- 仅Hc和HN-L抗原产生强保护效果并提供完全免疫保护。
- 联合疫苗组显示抗原组合后免疫应答无协同效应,提示毒素抗原或结构域的完整性对免疫效果至关重要。
- 剂量依赖性免疫保护效应研究进一步证实,Hc域抗原的保护效力比HN-L抗原更有效,相当于全长毒素(Hc+HN-L组合组)的免疫效果。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Botulinum neurotoxins (BoNTs) are highly toxic proteins that mediate their effects by binding to neuronal receptors and block the neutralizing ability of therapeutic antibodies. Vaccination is currently the most effective strategy to prevent botulism. In this study, a series of recombinant functional domain antigens of BoNT/A were prepared and identified, and their immunoprotective efficacies were explored and compared. Our results showed that all antigens produced strong humoral immune responses, although their protective effects against the toxin were different. Only the Hc and HN-L antigens produced strong protective effects and afforded complete immunoprotection. In addition, the combined vaccine groups showed that there was no synergistic effect on immune responses after antigen combination, suggesting that the integrity of the toxin antigen or domain is crucial to the immune effects. Studies of the dose-dependent immunoprotective effects further confirmed that the Hc domain antigen afforded more effective protective potency than the HN-L antigen, equivalent to the immune effect of the full-length toxin (Hc + HN-L combination group). Overall, our results demonstrated that the Hc domain elicited a strong protective immune response and also provided basic data and theoretical support for the development of Hc-based BoNT/A subunit vaccine. Therefore, the receptor binding domain Hc is implicated as a promising target antigen of the BoNT/A recombinant subunit vaccine as an alternative to the toxoid vaccine.
引用
- Liu FJ, Shi DY, Mao YY, et al. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A. Vaccine. 2020. PMID: 32113807. doi:10.1016/j.vaccine.2020.02.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。